Evidence map›Paper›PMID 32038729›Full record

ArticleResearch in pharmaceutical sciences2019

Nano-SnCl

Leila Zamani, Zeinab Faghih, Kamiar Zomorodian, Bi Bi Fatemeh Mirjalili, Asghar Jalilian, Soghra Khabnadideh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research in pharmaceutical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 19 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Leila ZamaniPharmaceutical Sciences Research Centre, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Zeinab FaghihPharmaceutical Sciences Research Centre, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Kamiar ZomorodianCenter of Basic Researches in Infectious Diseases, Department of Medical Mycology, and Parasitology School of Medicine, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Bi Bi Fatemeh MirjaliliDepartment of Chemistry, College of Science, Yazd University, Yazd, I.R. Iran.
Asghar JalilianPharmaceutical Sciences Research Centre, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Soghra KhabnadidehPharmaceutical Sciences Research Centre, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Shiraz University of Medical Sciences · IRYazd University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of green chemistry has made significant impact on many frontages including the use of green solvents or sustainable catalyst materials. Benzimidazole ring is an important nitrogen-containing heterocyclic, which exhibits a broad spectrum of bioactivities and are widely utilized by the medicinal chemists for drug discovery. A simple and efficient method was developed for the synthesis of some benzimidazole derivatives

Indexed as

AntifungalBenzimidazoleCytotoxicMTTNano-SnCl4/SiO2

Identifiers

PMID32038729
PMCPMC6937748
OpenAlexW2995374437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.